News | April 28, 2023
Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea
Apollo continues to invest in genomics technology and research for better patient care
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Subscribe To Our Newsletter & Stay Updated
